These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2637244)

  • 1. Serum soluble interleukin 2 receptor in patients with IgA nephropathy.
    Yorioka N; Hirabayashi A; Takemasa A; Kanahara K; Takahashi N; Oda H; Joarder ZH; Harada S; Yamakido M
    Hiroshima J Med Sci; 1989 Dec; 38(4):169-71. PubMed ID: 2637244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
    Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
    Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of soluble receptors for interleukin-2 in the serum of patients with rheumatoid arthritis].
    Pavelka K
    Cas Lek Cesk; 1990 Dec; 129(50):1582-5. PubMed ID: 2272075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble interleukin-2 receptor in patients with glomerulonephritis.
    Yorioka N; Hirabayashi A; Kanahara K; Takemasa A; Oda H; Joarder ZH; Yamakido M
    Am J Nephrol; 1990; 10(3):181-5. PubMed ID: 2382679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical use of serum beta-2-microglobulin and fractional beta-2-microglobulin excretion in IgA nephropathy.
    Lai KN; Lai FM; Vallance-Owen J
    Clin Nephrol; 1986 May; 25(5):260-5. PubMed ID: 3522000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro study of expression of interleukin-2 receptors in T-lymphocytes from patients with IgA nephropathy.
    Lai KN; Leung JC; Lai FM
    Clin Nephrol; 1988 Dec; 30(6):330-4. PubMed ID: 2977310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of interleukin-2 receptor and disease activity in patients with IgA nephropathy.
    Tomino Y; Ozaki T; Koide H; Takahashi M; Ito K
    J Clin Lab Anal; 1989; 3(6):355-9. PubMed ID: 2482345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of the soluble receptor for interleukin-2 in serum of patients with rheumatoid arthritis.
    Pavelka K
    Czech Med; 1991; 14(3):164-72. PubMed ID: 1807934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of bacterial antigens in immunoglobulin A nephropathy.
    Hirabayashi A; Yorioka N; Oda H; Sekiguchi Y; Kuramoto A; Okushin S; Yamakido M
    Hiroshima J Med Sci; 1996 Dec; 45(4):113-7. PubMed ID: 9119709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between intestinal permeability and antibodies against food antigens in IgA nephropathy].
    Kovács T; Mette H; Per B; Kun L; Schmelczer M; Barta J; Jean-Claude D; Nagy J
    Orv Hetil; 1996 Jan; 137(2):65-9. PubMed ID: 8721870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of complement 3 receptors (CR1 and CR3) on neutrophils and erythrocytes in patients with IgA nephropathy.
    Tao K; Nicholls K; Rockman S; Kincaid-Smith P
    Clin Nephrol; 1989 Nov; 32(5):203-8. PubMed ID: 2684457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
    Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Kobayashi Y; Hiki Y; Okamoto M
    J Nephrol; 2005; 18(5):575-81. PubMed ID: 16299684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of soluble Fas and disease activity in patients with IgA nephropathy.
    Shou I; Tashiro K; Kurusu A; Kaneko S; Hayashi T; Fukui M; Shirato I; Kubota K; Tomino Y
    Nephron; 1999; 81(4):387-92. PubMed ID: 10095173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food antigens, IgA-immune complexes and IgA mesangial nephropathy.
    Fornasieri A; Sinico RA; Maldifassi P; Paterna L; Benuzzi S; Colasanti G; D'Amico G
    Nephrol Dial Transplant; 1988; 3(6):738-43. PubMed ID: 3147415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
    Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
    J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease).
    Sinico RA; Fornasieri A; Oreni N; Benuzzi S; D'Amico G
    J Immunol; 1986 Jul; 137(2):536-41. PubMed ID: 3722816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
    Liu X; An H; Jiang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased concentration of serum IgA antibody to pneumococcal polysaccharides in patients with IgA nephropathy.
    Drew PA; Nieuwhof WN; Clarkson AR; Woodroffe AJ
    Clin Exp Immunol; 1987 Jan; 67(1):124-9. PubMed ID: 3497740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.